(INNF)
TAVOLIMAB(INNS)
TAVOLIMAB(SLE)
TAVOLIMAB(INNC)
IMMUNOGLOBULIN G1-KAPPA, ANTI-[HOMO SAPIENS TNFRSF4 (TUMOR NECROSIS FACTOR RECEPTOR (TNFR) SUPERFAMILY MEMBER 4, OX40, CD134)], HUMANIZED AND CHIMERIC MONOCLONAL ANTIBODY; GAMMA1 HEAVY CHAIN (1-451) [CHIMERIC VH (MUS MUSCULUS IGHV3-8*02 -(IGHD)-HOMO SAPIENS IGHJ4*01) [8.7.15] (1- 121) -HOMO SAPIENS IGHG1*03, G1M3 (CH1 (122-219), HINGE (220-234), CH2 (235-344), CH3 (345-449), CHS (450-451)) (122-451)], (224-214')-DISULFIDE WITH KAPPA LIGHT CHAIN (1'-214') [HUMANIZED V-KAPPA (HOMO SAPIENS IGKV1-39*01 (88.40%) -IGKJ1*01) [6.3.9] (1'-107') -HOMO SAPIENS IGKC*01, KM3 (108'-214')]; DIMER (230-230'':233- 233'')-BISDISULFIDE, RECOMMENDED INN: LIST 80(WHO)
TAVOLIMABUM(INN)